Search

Displaying results 9091 - 9100 of 10000 in total
  1. Drug

    FAV-201

    go.drugbank.com/drugs/DB06130
    Experimental

    FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.

  2. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  3. Drug

    Otilimab

    go.drugbank.com/drugs/DB06303
    Investigational

    Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).

  4. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  5. Drug

    Lerdelimumab

    go.drugbank.com/drugs/DB06557
    Experimental

  6. Drug

    Triphendiol

    go.drugbank.com/drugs/DB06588
    Experimental

  7. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  8. Drug

    Celgosivir

    go.drugbank.com/drugs/DB06580
    Investigational

  9. Drug

    BGB-DXP593

    go.drugbank.com/drugs/DB16357
    Investigational

    [L27401] It is currently being investigated against COVID-19 in the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants

  10. Drug

    Tasurgratinib

    go.drugbank.com/drugs/DB21222
    Investigational

    The usage of the INN stem '-gratinib' in the name indicates that Tasurgratinib is a fibroblast growth factor receptor (FGFR) inhibitor. … Tasurgratinib is under investigation in clinical trial NCT04962867 (NCCH2006/MK010 Trial (FORTUNE Trial)). Tasurgratinib has a monoisotopic molecular weight of 587.27 Da.

    Synonyms: E 7090